Pfizer could owe NHS England over £5 million in prescribing costs if it loses a patent appeal for painkiller and epilepsy drug pregabalin , branded Lyrica, according to a study.
27 February 2018
23 February 2018
The requirement for effective supportive care of cancer patients is expected to grow over the coming decade as survival rate increases and disease progression results in a chronic condition, according...
16 February 2018
Sales of melanoma-treating drugs will grow from an estimated $3.3bn during 2016 to $5.5bn in 2026, according to a report by GlobalData.
9 February 2018
The global glaucoma market is expected to witness a compound annual growth rate (CAGR) of 4.1%, rising from $2.6bn in 2016 to $3.8bn in 2026, according to a report by...
26 January 2018
Pharmaceutical Research and Manufacturers of America (PhRMA) spent $25.4 million lobbying the US Congress during 2017.
15 December 2017
Sales of multiple sclerosis (MS) disease-modifying therapies (DMTs) are projected to grow from $19.1bn in 2016 to $25.3bn in 2026, according to a report by GlobalData.
24 November 2017
Singapore’s pharmaceutical market is expected to increase from $903m in 2016 to $1.15bn in 2021 in value, representing a compound annual growth rate of approximately 5%, according to a report...
17 November 2017
Economic and political turmoil in Venezuela is anticipated to affect the growth rate of the domestic pharmaceutical market, according to a report by GlobalData.
2 November 2017
The recent FDA approvals of the first two gene therapies marked a groundbreaking new era for the medical world.
20 October 2017
Indonesia’s pharmaceutical market is projected to reach $10.11bn by 2021, according to a report by GlobalData.